News

Biotage® PhyPrep is back and better than ever.

Biotage is excited to introduce the Biotage® PrepXpert-8, a fully automated 8-channel sample preparation system designed to streamline high-throughput workflows in environmental and PFAS analysis. Bui...

When you think of a flash chromatography system, it’s easy to picture the pumps, valves, and columns. But for scientists, it’s the software that shapes their daily experience.

Biotage, a leading provider of innovative and sustainable solutions for drug discovery, development, and analytical testing, today announced the launch of the Isolera™ LS 150, a fully automated flash ...

Uppsala, Sweden, [20th Feb 2025]: Biotage, a leading provider of innovative and sustainable solutions for drug discovery, development, and analytical testing, is pleased to announce the appointment of...

Key Organics, a Cornwall-based contract research organization (CRO), has extensive expertise in synthetic organic chemistry. Established in 1986, the company has been a frontrunner in providing custom...

Biotage, the Global Go-To Separations Company, announces the launch of Biotage® PeptiPEC-96. This advanced, parallel peptide purification solution provides a fast and more environmentally sustainable ...

Biotage, the Global Go-To Separations Company, announces the launch of Biotage® Selekt ELSD, an advanced evaporative light-scattering detector for compound detection. Designed for compatibility with t...

The World Anti-Doping Agency (WADA) has granted accreditation to the French Anti-Doping Laboratory (LADF) at the University of Paris-Saclay as one of the thirty globally authorized laboratories for co...

Biotage® PeptiPEC high-throughput kits facilitate fast and low solvent consumption solution for plate-based peptide purification Partnership complements Gyros’ PurePep® EasyClean technology offering w...

Biotage launches an innovative sensor technology* that allows scientists to monitor their liquid levels in real time during flash purification. Biotage® Liquid Level Sensor, compatible with the entire...

Biotage launches a high-throughput solution for parallel peptide purification that further automates the drug discovery workflow for peptides. The new Biotage® PeptiRen-96 well plates together with th...

Biotage has completed the acquisition of Astrea Bioseparations, a high-growth chromatography solutions provider from Gamma Biosciences, a life sciences tools platform created by KKR.

Biotage announces the launch of two new connectivity solutions for the leading Biotage® Selekt family of flash purification systems. The first is ‘Biotage® Selekt Remote Control’, allowing a system fr...

Uppsala, Sweden – 15 February 2023 – Biotage AB (publ) (“Biotage”) has entered into an agreement to acquire Astrea Bioseparations (“Astrea”), a high-growth chromatography solutions provider from Gamma...

Tomas Blomquist, President and CEO: Even though the end of the year was less satisfactory than we would have wanted, I can still say that 2022 was the best year in our 25-year history. Biotage grew ra...

Doubling the company’s footprint in Silicon Valley, a hot spot for the promising Biologics and Advanced Therapeutics area, is a testament to Biotage’s commitment and priority to continuously invest an...

Funded by academia, Vinnova and industry, a five-year multi-disciplinary collaboration has been launched to improve efficiency in production methods for adeno-associated virus (AAV) based gene therapi...

Biotage has launched the new Biotage® Selekt Enkel Flash Purification System, a new member of the Selekt family of instruments. Maintaining the small footprint, powerful interface, quality and robustn...

Biotage has launched the Biotage® Extrahera™ HV-5000, an automated workstation dedicated to column-based sample preparation that is able to aspirate and dispense high volume samples. The system mainta...

Biotage have published their annual report for 2021 giving end of year results for the entire organisation.

Plasmids are the common starting material for viral vectors, recombinant proteins, mRNA and DNA vaccines. With the rapid growth of interest in cell therapy, gene therapy and advanced therapeutics, the...

The recent global pandemic has illustrated that the development of smarter healthcare is a global need, as acknowledged by the U.N.’s sustainable development program. Biotage has recognized this trend...

Biotage AB has acquired ATDBio and strengthened its position in DNA and RNA Oligonucleotide synthesis and purification.

Biotage AB has today entered into an agreement to acquire all outstanding shares in the privately held company ATDBio Limited based in Oxford and Southampton, UK. The acquisition of ATDBio adds import...

Large-scale chromatography is often the only solution to the purification of valuable drug compounds in the pharmaceutical industry. In many cases, a commercially available purification system specifi...

Biotage are pleased to announce the launch of the new Biotage® Extrahera™ LV-200, is a GLP capable, automated sample preparation workstation dedicated to 96-well arrays for microelution technologies a...

Biotage are pleased to announce the launch of the Biotage® PhyPrep, an automated solution for the endotoxin-free purification of plasmids on the Maxi, Mega and Giga scales. Visit our Drug Discovery pr...

Read how Biotage collaborated with Croda to scale up the purification of lipids used in the manufacturing of mRNA (messenger RNA) vaccines. The use of Biotage automated laboratory scale purification s...

The TurboVap® series of evaporators is an established market leader across the globe. Now, with the launch of the new TurboVap® 96 Dual, Biotage expands the family and re-defines evaporation. Our new ...

Biotage is committed to sustainability at every level within the company and within every customer relationship. EcoVadis, a leading producer of supplier sustainability ratings, recently recognize thi...